Navigation Links
Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Date:8/6/2009

THOUSAND OAKS, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that Vectibix((R)) (panitumumab), administered in combination with FOLFOX (an oxaliplatin-based chemotherapy), significantly prolonged progression-free survival (PFS) compared with FOLFOX alone in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer (mCRC).

"We believe that these data document an important advance for patients with metastatic colorectal cancer," said Roger M. Perlmutter, M.D., Ph.D., executive vice president of Research and Development at Amgen. "These are the first prospective Phase 3 data to demonstrate the utility of KRAS mutational analysis as a predictive biomarker."

Overall, the adverse event profile was as anticipated for an anti-EGFR antibody in combination with oxaliplatin-based chemotherapy, including known events such as skin toxicity, hypomagnesemia and diarrhea.

Originally designed to compare the treatment effect in the overall population, the study was amended to analyze outcomes with respect to the presence or absence of activating mutations in KRAS in the tumor itself. Tumor KRAS status was ascertained in more than 90 percent of the 1,183 patients enrolled in the trial.

Importantly, in patients with tumors harboring activating KRAS mutations, PFS was significantly inferior in the Vectibix arm. These data confirm previous findings when oxaliplatin-based chemotherapy and an anti-EGFR antibody are combined.

"Our study underscores the importance of KRAS status in identifying the appropriate patient population to be treated with Vectibix, consistent with worldwide labeling," said Perlmutter. "Not only is the improvement in progress
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
2. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
3. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
4. Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL
5. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
6. Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
7. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
8. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
9. New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
10. Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma
11. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... , Sept. 20, 2014 /CNW/ - The issue: Mylan Pharmaceuticals ... all lots of its Mylan-Nitro Spray 0.4 mg/metered dose due ... of the pump component. A missing "dip ... nitroglycerin to the patient. This defect may lead patients to ... are unable to access it. Not receiving nitroglycerin could place ...
(Date:9/19/2014)... HILL, N.C. , Sept. 19, 2014 /PRNewswire/ ... role in forging relationships with key opinion leaders ... market and competition. Despite the critical nature of ... created many challenges, including altering the landscape for ... According to research, the oversight responsibility ...
(Date:9/19/2014)... YORK , Sept. 19, 2014 Harwood ... against the board of directors of PDL BioPharma, Inc. ... concerning whether the board has breached its fiduciary duties ... On September 16, 2014, the Company disclosed: "On ... independent registered accounting firm, Ernst & Young LLP ("EY"), ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... Ortho Biotech today announced that 12,clinical studies of ... at the 49th annual meeting of the American ... Center on December 8-11,2007., "We are very ... said Craig Tendler, M.D., Vice President, Medical Affairs,Oncology/Nephrology, ...
... Genoptix, Inc. (Nasdaq:,GXDX), a provider of personalized ... Atlanta, Georgia, that it will launch testing for ... expands the Genoptix service,offering for patients with hematomalignancies, ... management. Genoptix believes it will be the first,commercial ...
Cached Medicine Technology:Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 2Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 3Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 4Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 5Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 6Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 7Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 8Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 9Genoptix, Inc. Announces Availability of MPL W515 L/K Mutation Analysis for MPD at 49th Annual American Society of Hematology (ASH) Meeting 2Genoptix, Inc. Announces Availability of MPL W515 L/K Mutation Analysis for MPD at 49th Annual American Society of Hematology (ASH) Meeting 3
(Date:9/20/2014)... (PRWEB) September 20, 2014 David Cooke ... 2014. The first poster looked at the clinical benefits ... cycle for calculating diastolic function. In conjunction with colleagues ... renal disease and normal LVEF by echo (>50%). Each ... protocol, and standard SPECT. Emory Toolbox 4.0 ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 The Villa ... Villa del Palmar Cabo San Lucas, Villa La Estancia ... to Hurricane Odile, with plans to welcome guests back ... As of Sept. 19, all members and guests of ... thanks to a coordinated effort with government authorities. ...
(Date:9/20/2014)... Mexico (PRWEB) September 20, 2014 Villa ... the resort did not experience any damage in relation ... amenities and activities available. , Hurricane Odile struck Cabo ... intense wind, rain and powerful surf conditions. Located on ... Palmar Islands of Loreto experienced some heavy rain, but ...
(Date:9/20/2014)... Increases in household, construction and ... treatment volumes. However, government regulations and higher landfill ... According to IBISWorld industry analyst Alen Allday, “over ... at reducing the volume of waste generated, and ... Still, a large proportion of waste generated by ...
(Date:9/20/2014)... Ticket Down is a dependable source for ... ticket exchange is offering their customer appreciation promo code ARIANA-2015 ... tours is beginning to fill up. Many of the biggest ... the road, including 21-year-old pop superstar, Ariana Grande. Grande, a ... will take her to 25 cities across the United States ...
Breaking Medicine News(10 mins):Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Villa Group Resorts in Cabo Largely Unharmed, Plan to Re-open Early October 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3
... A new comparison of the procedures to help prevent ... of the neck concludes they are equally effective at ... surgery or a minimally invasive treatment using wire coils ... six percent. Results of the analysis were detailed in ...
... blood test to help diagnose major depressive disorder indicates ... a paper published in the journal Molecular Psychiatry ... reports that a test analyzing levels of nine biomarkers ... without significant false-positive results. "Traditionally, ...
... Reinberg HealthDay Reporter , TUESDAY, Jan. 31 ... to control indigestion and heartburn may put themselves at ... use of these drugs, called proton pump inhibitors (PPIs), ... percent for current or former smokers, the researchers added. ...
... you are a people-pleaser who strives to keep your social ... certain social situations like Super Bowl watch parties. A new ... not, some people eat in an attempt to keep others ... upset the sense of social harmony," says Julie Exline, a ...
... TUESDAY, Jan. 31 (HealthDay News) -- Physicians can boost their chances ... flexible sigmoidoscopy test, which is a less invasive procedure than ... at the value of following up a negative flexible sigmoidoscopy test ... repeat test. However, "you don,t find twice as many [signs ...
... new therapies and data on the relative benefits of ... advance of the fourth annual Genitourinary Cancers Symposium, being ... Marquis in San Francisco, Calif. The results of ... briefing via live webcast): 1) Vigorous Exercise Linked ...
Cached Medicine News:Health News:Stents and surgery for blocked neck arteries are neck-and-neck as lasting stroke prevention 2Health News:Stents and surgery for blocked neck arteries are neck-and-neck as lasting stroke prevention 3Health News:Blood test accurately distinguishes depressed patients from healthy controls 2Health News:Blood test accurately distinguishes depressed patients from healthy controls 3Health News:Heartburn Drugs May Raise Fracture Risk in Older Women 2Health News:Heartburn Drugs May Raise Fracture Risk in Older Women 3Health News:Hold the extra burgers and fries when people pleasers arrive 2Health News:Alternative to Colonoscopy Spots Cancers, Too 2Health News:Research from the 2012 Genitourinary Cancers Symposium highlights new treatments, compares existing therapies for prostate cancer 2
Research Series 2100 Adjustable-volume Pipette, 2.0-20 l, single-channel with adjustable-volume setting...
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
The Pall High Performance HME is a high efficiency heat and moisture exchanger, indicated to protect patients against the potential risks of ventilation with dry and cold gases....
Medicine Products: